OICR News / Tag

Clinical trials

Browse news tagged Clinical trials.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

TechnologyProstate cancer

Prostate cancer trial aims to deliver shorter, more effective radiotherapy thanks to advanced imaging

Sophisticated imaging tools are being used together to guide high-dose radiation that provides safe and effective treatments in a shorter timeframe. For John Hodges, the math was simple. Five radiation treatments sounded better than 28.…

ArticleAug 24, 2022

TalentPancreatic cancer

Trusting the gut in cancer research: Q&A with Dr. Saman Maleki

OICR’s new Early Career Investigator is harnessing the gut microbiome’s immunogenic properties to improve cancer patients’ response to immunotherapy. To make progress against a disease as complex as cancer, Dr. Saman Maleki thinks it’s important…

ArticleAug 15, 2022

TalentClinical trials

OICR announces funding for three new window-of-opportunity clinical trials

Trials are part of OICR’s Window-of-Opportunity Network June 16, 2022 — Toronto — The Ontario Institute for Cancer Research (OICR) is announcing funding for three new Ontario-based clinical trials as part of its Window-of-Opportunity (WOO)…

ArticleJun 16, 2022

TalentClinical trials

New research asks if clinical trials are losing sight of what matters most to cancer patients

Dr. Bishal Gyawali says research into new cancer drugs should focus on outcomes like quality of life and overall survival. Cancer therapies should help people live longer or live better, and ideally they should do…

ArticleMay 10, 2022

CollaborationClinical trials

Mapping the Canadian clinical trials landscape in precision oncology to identify trial opportunities for patients, clinicians and researchers

Toronto – (December 15, 2021) With funding provided through the Precision Oncology Patient Innovation Award from Bayer, the Canadian Cancer Clinical Trials Network (3CTN) will create the Precision Oncology Map, a uniquely comprehensive, visual representation…

ArticleDec 15, 2021

Talent

New OICR Investigator aims to improve cancer treatment in Ontario and worldwide

Dr. Bishal Gyawali, based at Queen's University, is an expert in global oncology, cancer policy, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, supportive care, and global oncology. The emergence of new cancer therapies and…

ArticleJun 09, 2021

← Previous Next stories →

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.